Reply to: "Probability of HBsAg loss after nucleos(t)ide analogue withdrawal depends on HBV genotype and viral antigen levels"

Milan J. Sonneveld*, Shao Ming Chiu, Chien Hung Chen, Benjamin Maasoumy, CREATE study group

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)1224-1226
Number of pages3
JournalJournal of Hepatology
Issue number4
Publication statusPublished - 1 Oct 2022

Bibliographical note

Financial support
The CREATE study was supported by Fujirebio. Materials for HBcrAg testing were provided free of charge to several participating centers.

Cite this